{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:10:06Z","timestamp":1781737806663,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.amjcard.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T01:59:47Z","timestamp":1569463187000},"page":"1889-1893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-8701","authenticated-orcid":false,"given":"Mohammed","family":"Ruzieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan K.","family":"Moroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader M.","family":"Aboujamous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Ghahramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mandrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Foy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.09.008_bib0001","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1378\/chest.125.2.377","article-title":"Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses","volume":"125","author":"Kochiadakis","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0004","doi-asserted-by":"crossref","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, 2014;64:2246\u20132280.","DOI":"10.1016\/j.jacc.2014.03.021"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0005","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.CIR.67.1.45","article-title":"Side effects of long-term amiodarone therapy","volume":"67","author":"Harris","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0007","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/chd.12657","article-title":"Adverse effects of amiodarone therapy in adults with congenital heart disease","volume":"13","author":"Moore","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0008","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.CIR.82.1.51","article-title":"Clinical features of amiodarone induced pulmonary toxicity","volume":"82","author":"Dusman","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0009","first-page":"419","article-title":"Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure","volume":"18","author":"Mattar","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.amjcard.2019.09.008_bib0010","first-page":"11","article-title":"How toxic is amiodarone to the liver?","volume":"19","author":"Pollak","year":"2010","journal-title":"J Gastrointestin Liver Dis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491931046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491931046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:31:58Z","timestamp":1757572318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491931046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S000291491931046X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.008","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}